We want to hear from nurses about your comfort in having end-of-life discussions.
When treating patients with cancer, end-of-life (EOL) discussions are often part of the care continuum. Oncology nurses should be ready to have these conversations — which can include advance directives, palliative or hospice care, and more – with patients and their loved ones.
We want to hear your thoughts on EOL discussions — are you comfortable having those talks, what questions do you have, and what advice would you give to other nurses? To share, take the Oncology Nursing News survey: https://www.surveymonkey.com/r/PQZCH36
The COVID-19 pandemic has also changed the way health care providers face EOL care, as many hospitals and clinics have adopted no-visitor policies. Some bend these rules for patients who are at the end of their lives. Either way, nurses are faced with these discussions day after day.
To hear about EOL discussions and more, register for the 4th Annual School of Nursing Oncology live, interactive meeting.
FDA Grants Full Approval to Mirvetuximab Soravtansine for Pretreated Gynecologic Cancers
March 22nd 2024Mirvetuximab soravtansine received full approval from the FDA for pretreated adult patients with FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Immunotherapy May Address ‘Huge Need’ in Advanced Endometrial Cancer
March 22nd 2024Amanda Duck, PA-C, RD, held a discussion during a Community Case Forum on the progress made in using immunotherapy to treat patients with advanced endometrial cancer and the creativity sometimes needed to address adverse events.